Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2025-12-31 @ 2:12 AM
Study NCT ID:
NCT01897233
Status:
COMPLETED
Last Update Posted:
2017-06-20
First Post:
2013-07-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Lumacaftor in Combination With Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-07
Start Date Type:
None
Primary Completion Date:
2015-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-10
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-08
First Submit QC Date:
None
Study First Post Date:
2013-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-10-07
Results First Submit QC Date:
None
Results First Post Date:
2016-12-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-23
Last Update Post Date:
2017-06-20
Last Update Post Date Type:
ACTUAL